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Abstract
Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in
China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases
of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles.
Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood
glucose and WBC counts in cases of HFMD until 15
th June 2011, and quantitatively summarized the characteristics of them
using meta-analysis.
Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood
glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the
illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system
dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood
glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in
cases infected by CA16.
Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which
would help doctors to manage patients efficiently.
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Introduction
Hand foot and mouth disease (HFMD), which was first reported
in New Zealand in 1957, is an unremarkable illness that
commonly occurs in young children, most of whom are younger
than 5 years old. Two closely related viruses, coxsackievirus A16
(CA16) and enterovirus 71 (EV71), which belong to the Enterovirus
genus of the Picornavirus family, and usually co-circulate during
HFMD outbreaks [1–3], have been identified as the most frequent
pathogens of HFMD, and other enteroviruses, including CA2,
CA4, CA5, CA7, CA9, CA10, CA16, CB1, CB2, CB3, CB4 and
CB5 can also cause HFMD. In the most common manifestation
which gives the syndrome its name, children typically present with
vesicular exanthema on the soles of their feet, the palms of their
hands and in their mouths, causing discomfort and feeding
difficulties. However, severe health consequences or deaths may
occur owing to complications such as encephalitis, aseptic
meningitis, acute flaccid paralysis, myocarditis, autonomic nervous
system dysregulation (ANS) and pulmonary edema (PE) or
hemorrhage.
In recent years, outbreaks of HFMD have increased and more
and more severe cases have appeared, especially in China [4],
which has posed a persistent and severe public health problem.
Severe HFMD cases have many characteristics in laboratory
diagnosis. Hyperglycemia and leukocytosis are two important
characteristics in severe cases of HFMD, and blood glucose and
white blood cell (WBC) counts change with the severity of the
disease, which have been addressed by multiple studies such as
those reported by Mao et al [5] and Yu et al [6], and the results
are not always consistent. Meta-analysis and systematic review can
solve these disputes. To our knowledge, these data have not been
systematically evaluated and reported in English. The objective of
this study was to summarize the data and evaluate the
characteristics of these indexes in patients of HFMD using a
meta-analysis of published articles.
Materials and Methods
Literature search
Studies addressing blood glucose and/or WBC counts in cases of
HFMD were identified by searching for articles in the MEDLINE
database and WANFANG Data until 15
th June, 2011. WANFANG
Data is an affiliate of Chinese Ministry of Science & Technology and
has been the leading information provider in China since 1950 s.
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e29003Figure 2. Meta-analysis of the level of blood glucose between healthy controls and mild cases of HFMD. Each comparison was
presented by the name of the first author and the year of the publication. The studies were shown by a point estimate of the MD and the
accompanying 95%CI which were displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight
which was obtained by contribution to the pooled MD estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact
was quantified by I
2 which can range between 0 and 100%.
doi:10.1371/journal.pone.0029003.g002
Figure 3. Meta-analysis of the level of blood glucose between mild cases and severe cases of HFMD. Each comparison was presented by
the name of the first author and the year of the publication. The studies were shown by a point estimate of the MD and the accompanying 95%CI
which were displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight which was obtained by
contribution to the pooled MD estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact was quantified by I
2
which can range between 0 and 100%.
doi:10.1371/journal.pone.0029003.g003
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WANFANG Data has become a gateway to understand Chinese
culture, medicine, business, science, etc.
Various combinations of the English terms as well as the
corresponding Chinese terms ‘‘enterovirus’’, ‘‘enterovirus 71’’,
‘‘EV’’, ‘‘EV71’’, ‘‘hand foot and mouth disease’’, ‘‘HFMD’’, ‘mild
cases’’, ‘‘severe cases’’, ‘‘blood glucose’’, ‘‘hyperglycemia’’, ‘‘leu-
kocyte’’, ‘‘white blood cell counts’’, ‘‘WBC counts’’ and ‘‘leuko-
cytosis’’ were used to screen for potentially relevant studies.
Additional studies were also identified using cross-referencing.
Inclusion and exclusion criteria
Studies addressing blood glucose and/or WBC counts, healthy
controls and mild cases of HFMD, and/or mild cases and severe
cases of HFMD, and/or cases with central nervous system (CNS)
and cases with autonomic nervous system dysregulation (ANS)
and/or pulmonary edema (PE) [4] and/or cases infected by EV71
(EV71) and cases infected by CA16 (CA16) were included. If the
study was reported in duplicate, the article published with more
cases was included. Normally, the levels of blood glucose range
from 3.89 mmol/L to 6.11 mmol/L [7].When the level of blood
glucose is more than 6.11 mmol/L or random blood glucose level
is more than 11.1 mmol/L, it is defined as hyperglycemia. In
regular health checkup, WBC counts in peripheral blood are
4,10610
9 cells/L [8] and it is defined as leukocytosis when WBC
counts are more than 10610
9cells/L. Sometimes hyperglycemia
and leukocytosis were defined in a different way. In the included
studies, the screening of blood glucose was usually performed by
Figure 4. Meta-analysis of the prevalence of hyperglycemia between mild cases and severe cases of HFMD. Each comparison was
presented by the name of the first author and the year of the publication. The studies were shown by a point estimate of the OR and the
accompanying 95%CI which were displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight
which was obtained by contribution to the pooled OR estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact
was quantified by I
2 which can range between 0 and 100%.
doi:10.1371/journal.pone.0029003.g004
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were performed by Hematology Analyzer on admission. A
diagnosis of HFMD was made based on typical clinical symptoms,
abiding by the handbook of treatment for HFMD issued by the
Ministry of Health of the People’s Republic of China. According
to the handbook, mild cases of HFMD are defined as being
present with fever, vesicular exanthema on the palms of their
hands, on the soles of their feet and in their mouths, while severe
cases are defined as HFMD cases complicated with encephalitis,
aseptic meningitis, acute flaccid paralysis, myocarditis, ANS, PE,
pulmonary hemorrhage, severe sequelae or even death. Review
articles, studies in languages other than English or Chinese, studies
Figure 5. Meta-analysis of WBC counts between mild cases and severe cases of HFMD. Each comparison was presented by the name of
the first author and the year of the publication. The studies were shown by a point estimate of the MD and the accompanying 95%CI which were
displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight which was obtained by contribution to
the pooled MD estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact was quantified by I
2 which can range
between 0 and 100%.
doi:10.1371/journal.pone.0029003.g005
Figure 6. Meta-analysis of the prevalence of leukocytosis between mild cases and severe cases of HFMD. Each comparison was
presented by the name of the first author and the year of the publication. The studies were shown by a point estimate of the OR and the
accompanying 95%CI which were displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight
which was obtained by contribution to the pooled OR estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact
was quantified by I
2 which can range between 0 and 100%.
doi:10.1371/journal.pone.0029003.g006
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and mild cases of HFMD or CNS and ANS and/or PE or cases
infected by EV71 and cases infected by CA16, studies with mild
cases of HFMD only or severe cases of HFMD only, the levels of
blood glucose and/or WBC counts not being present as mean and
standard deviation (x6s), the level of glucose and/or WBC counts
in cerebrospinal fluid and case report, were excluded.
Data extraction and Statistical analysis
For all included studies, we extracted the following data from
original publications: first author and year of publication, sample
size and age of the participants, male to female ratio, the
diagnosis criteria of HFMD, the diagnosis criteria of hypergly-
cemia and/or leukocytosis, the assay method of blood glucose
and/or WBC counts, the number of positive cases with
hyperglycemia and/or leukocytosis of HFMD, the positive rate
of cases with hyperglycemia and/or leukocytosis of HFMD, the
levels of blood glucose and/or WBC counts (x6s), location
rural/urban, absence of concomitant infections, ethnicity and
the assay time (Table S1, Table S2, Table S3, Table S4 and
Table S5). In the included studies, all the cases were collected
from hospitals. For some studies, events had to be calculated
from the reported data.
For each study, the odds ratio (OR) or mean difference (MD) of
the most adjusted model was used to estimate a pooled OR or
MD, which was obtained by the combinations of study-specific
ORs or MDs using fixed effects model (Mantel-Haenszel) [9] or
random effects model (DerSimonian and Laird) [10]. Random
effects model was more appropriate when heterogeneity appeared.
The significance of the pooled OR or MD was determined by the
Z test (P,0.05). Chi square based Q test was performed to assess
the between-study heterogeneity, which was considered significant
for P,0.10. The I
2 statistic for each analysis was calculated as a
measure of the proportion of the overall variation that was
attributable to between-study heterogeneity [11], which was
independent of the number of the studies in the meta-analysis.
I
2 took values form 0 to 100% with higher values denoting greater
degree of heterogeneity. Stratified analyses were performed
according to age.
All analyses were applied with Review Manager Software
version 5.0 (Cochrane Collaboration, Copenhagen, Denmark).
The software Stata (version 10.0) was applied for meta-regression
Figure 7. Meta-analysis of the level of blood glucose between CNS and ANS/PE. Each comparison was presented by the name of the first
author and the year of the publication. The studies were shown by a point estimate of the MD and the accompanying 95%CI which were displayed
on a logarithmic scale using a random effects model. The studies are sorted according to the weight which was obtained by contribution to the
pooled MD estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact was quantified by I
2 which can range
between 0 and 100%.
doi:10.1371/journal.pone.0029003.g007
Figure 8. Meta-analysis of the prevalence of hyperglycemia between CNS and ANS/PE. Each comparison was presented by the name of
the first author and the year of the publication. The studies were shown by a point estimate of the OR and the accompanying 95%CI which were
displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight which was obtained by contribution to
the pooled OR estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact was quantified by I
2 which can range
between 0 and 100%.
doi:10.1371/journal.pone.0029003.g008
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on blood glucose level (P,0.05).
Results
As shown in Fig. 1, a total of 422 articles published in Chinese
or English were identified. After excluding 4 review papers and
377 original articles without data about healthy controls and mild
cases of HFMD or mild cases and severe cases of HFMD or CNS
and ANS/PE or cases infected by EV71 and cases infected by
CA16 based on abstract evaluation, 45 studies were selected and
the full-text versions were retrieved. Of these, 8 were excluded
based on the exclusion criteria. Finally, 37 studies [5,6,12–48]
were included in this review. Among them, 33 studies, from
Mainland China, and 4 studies, from Taiwan, addressing blood
glucose and/or WBC counts in healthy controls and mild cases of
HFMD, or in mild cases of HFMD and severe cases of HFMD, or
in CNS and ANS/PE, or in cases infected by EV71 and cases
infected by CA16 were presented in Table S1, Table S2, Table S3
and Table S4.
Meta-regression
Using MD in the level of blood glucose between mild cases and
severe cases of HFMD, we performed a meta-regression to
investigate the potential interactions of age (total mean age of all
cases) and gender (total number of male cases). The P-value
(P,0.05) of age approached significance, which suggested that age
was a confounder and may cause high between-study heteroge-
neity. Therefore stratified meta-analysis on blood glucose should
be performed according to age.
Meta-analysis
Healthy controls and mild cases of HFMD. There were
only 2 studies pooled in this analysis. One study [13] reported that
the average level of blood glucose in mild cases of HFMD was
more than that in healthy control, while another study [12]
claimed that there was no significant difference between them.
Heterogeneity test of the 2 studies suggested that random effects
model be applied (P,0.0001). According to MD calculation
(Fig. 2), the average level of blood glucose in mild cases of HFMD
had a 0.9 mmol/L increment compared with that in healthy
controls (95%CI -0.41 mmol/L,2.21 mmol/L). However, this
effect was not statistically significant (P=0.18).
Mild cases and severe cases of HFMD. Eighteen studies
reported that the average levels of blood glucose in severe cases of
HFMD were more than those in mild cases of HFMD, while one
study [23] claimed that there was no significant difference between
them. Stratified analyses were performed according to the age-
matched, the age-unmatched and the age-unknown. Heterogeneity
test of the 19 studies suggested that random effects model be applied
(P,0.000 01). According to MD calculation (Fig. 3), the meta-
analyses of the age-matched, the age-unmatched and the age-
Figure 9. Meta-analysis of WBC counts between CNS and ANS/PE. Each comparison was presented by the name of the first author and the
year of the publication. The studies were shown by a point estimate of the MD and the accompanying 95%CI which were displayed on a logarithmic
scale using a random effects model. The studies are sorted according to the weight which was obtained by contribution to the pooled MD estimate.
Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact was quantified by I
2 which can range between 0 and 100%.
doi:10.1371/journal.pone.0029003.g009
Figure 10. Meta-analysis of the prevalence of leukocytosis between CNS and ANS/PE. Each comparison was presented by the name of the
first author and the year of the publication. The studies were shown by a point estimate of the OR and the accompanying 95%CI which were
displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight which was obtained by contribution to
the pooled OR estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact was quantified by I
2 which can range
between 0 and 100%.
doi:10.1371/journal.pone.0029003.g010
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severe cases of HFMD had a 3.10 mmol/L increment compared
with that in mild cases of HFMD (95%CI 2.29 mmol/
L,3.91 mmol/L, P,0.000 01).
Meta-analysis of the prevalence of hyperglycemia in mild cases
and severe cases of HFMD included 18 studies. Stratified analyses
were performed according to the age-matched, the age-un-
matched and the age-unknown. Heterogeneity test of the 18
studies suggested that random effects model be applied (P,0.000
01). According to OR calculation (Fig. 4), the meta-analyses of the
age-matched, the age-unmatched and the age-unknown were
consistent and the prevalence of hyperglycemia in severe cases of
HFMD accounted for 21.09% increment compared with that in
mild cases of HFMD (95%CI 10.65%,41.79%, P,0.000 01).
Thirteen studies reported that WBC counts in severe cases of
HFMD were more than those in mild cases of HFMD, while two
studies [24,30] claimed that there was no significant difference
between them. Heterogeneity test of the 15 studies suggested that
random effects model be applied (P,0.000 01). According to MD
calculation (Fig. 5), WBC counts in severe cases of HFMD had a
4.27610





Meta-analysis of the prevalence of leukocytosis in mild cases and
severe cases of HFMD included 11 studies. Heterogeneity test of
the 11 studies suggested that random effects model be applied
(P,0.000 01). According to OR calculation (Fig. 6), the
prevalence of leukocytosis in severe cases of HFMD had a
7.62% increment compared with that in mild cases of HFMD
(95%CI 3.96%,14.67%, P,0.000 01).
CNS and ANS/PE. Five studies reported that the average
levels of blood glucose in ANS/PE were more than those in CNS,
while one study [18] claimed that there was no significant
difference between them. Heterogeneity test of the 6 studies
suggested that random effects model be applied (P,0.000 01).
According to MD calculation (Fig. 7), the average level of blood
glucose in ANS/PE had a 4.17 mmol/L increment compared with
that in CNS (95%CI 2.24 mmol/L,6.11 mmol/L, P,0.000 01).
Meta-analysis of the prevalence of hyperglycemia in ANS/PE
and CNS of HFMD included 3 studies. Heterogeneity test of the 3
studies suggested that random effects model be applied (P=0.04).
According to OR calculation (Fig. 8), the prevalence of
hyperglycemia in ANS/PE had a 5.82% increment compared
with that in CNS (95%CI 1.26%,26.83%, P=0.02).
Four studies reported that WBC counts in ANS/PE were more
than those in CNS, while two studies [30,43] claimed that there was
no significant difference between them. Heterogeneity test of the 6
studies suggested that random effects model be applied (P=0.03).
According to MD calculation (Fig. 9), WBC counts in ANS/PE had
a 3.77610




Meta-analysis of the prevalence of leukocytosis in CNS and
ANS/PE included 2 studies. Heterogeneity test of the 2 studies
suggested that random effects model be applied (P,0.04).
According to OR calculation (Fig. 10), the prevalence of
leukocytosis in ANS/PE had a 3.18% increment compared with
that in CNS (95%CI 0.47%,21.43%). However, this effect was
not statistically significant (P=0.24).
Cases infected by EV71 and cases infected by CA16. One
study [48] reported that WBC counts in cases infected by EV71
were less than those in cases infected by CA16, while 3 studies [45–
47] claimed that there was no significant difference between them.
Heterogeneity test of the 4 studies suggested that fixed effects model
be applied (P=0.60). According to MD calculation (Fig. 11), WBC
countsincasesinfected byEV71 hada0.96610
9Cells/Ldecrement





Repeated outbreaks of HFMD have occurred in many parts of
the world such as Malaysia [49–50], Taiwan [1,51–54], Singapore
[55], Mainland China [56], Brunei [57], Western Australia [58],
the Unites States [59] and Germany [60]. The first reported large
and severe HFMD epidemic occurred in Taiwan region in 1998
including about 130 000 cases of HFMD, among whom 405
patients were severe cases and 78 died [1,51–52]. In 2000, there
was another report of outbreak, with 80 677 cases of HFMD and
41 deaths there [52]. In Mainland China, HFMD has occurred
repeatedly in recent years and more and more cases have been
reported. There were 83 344, 488 955 and 1 155 525 cases in the
nationwide in the year of 2007, 2008 and 2009, respectively,
reported by the Ministry of Health of the People’s Republic of
China. The corresponding deaths increased with years and were
17, 126 and 353 for these years, respectively. This suggested that
HFMD had become a severe public health problem in China.
Therefore it is necessary to find feasible indexes to monitor the
severity and prognosis of HFMD patients.
When children suffer from HFMD, the prevalence of hyperglyce-
mia, the prevalence of leukocytosis, the level of blood glucose and
WBC counts will change with the severity of the disease. In this article,
we performed a meta-analysis on these indexes respectively. To the
Figure 11. Meta-analysis of WBC counts between cases infected by EV71 and cases infected by CA16. Each comparison was presented
by the name of the first author and the year of the publication. The studies were shown by a point estimate of the MD and the accompanying 95%CI
which were displayed on a logarithmic scale using a random effects model. The studies are sorted according to the weight which was obtained by
contribution to the pooled MD estimate. Between-study heterogeneity was tested by the x
2-based Q-statistic, and its impact was quantified by I
2
which can range between 0 and 100%.
doi:10.1371/journal.pone.0029003.g011
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29003best of our knowledge, this is the first time to apply meta-analysis to the
prevalence of hyperglycemia, the prevalence of leukocytosis, the level of
blood glucose and WBC counts in cases of HFMD.
By using a search strategy, and inclusion criteria and exclusion
criteria, 37 studies were selected including 33 studies reported in
Mainland China and 4 studies reported in Taiwan. Far less was
known regarding the descriptive epidemiology of HFMD in
countries outside the Western Pacific Region [4]. It is unfortunate
that no studies reported in countries other than Mailand China
and Taiwan fulfilled our inclusion criteria to be included in our
analysis. Therefore our research focused on the characteristics of
blood glucose and WBC counts reported in Mainland China and
Taiwan. When children suffer from HFMD, the patients could
present different symptoms from the mild to the severe such as
HFMD, encephalitis, ANS and PE. The characteristics of blood
glucose and WBC counts which have been previously reported are
inconsistent. For example, one study [6] claimed that the average
level of blood glucose in mild cases of HFMD was higher than that
in healthy controls, but another study [5] claimed that there was
no significant difference between them. As another example, some
studies [8,13,27,37] claimed that WBC counts in ANS/PE were
higher than those in CNS but other studies [24,38] showed that
there was no significant difference between them. By meta-analysis
we solved the divergence between them and concluded that the
level of blood glucose, the prevalence of hyperglycemia, WBC
counts and the prevalence of leukocytosis increased with the
severity of the disease, but there was no significant difference in the
average level of blood glucose between mild cases of HFMD and
healthy controls. In the symptom-matched cases infected by EV71
and CA16, respectively, WBC counts were less in cases infected by
EV71 than those in cases infected by CA16. However, there were
not enough data available for meta-analysis of the level of blood
glucose between cases infected by EV71 and CA16, and of WBC
counts between mild cases of HFMD and healthy controls.
Blood glucose and WBC counts could help doctors manage
patients in 2 ways by judging the severity and prognosis. First, blood
glucose and WBC counts could reflect the severity of the illness. Lin
et al [9] reported that both the level of blood glucose and WBC
counts increased greatly from the mildest uncomplicated group to
the severest encephalitis with pulmonary edema group when
HFMD patients were divided into 3 groups: the uncomplicated
group, the encephalitis group and the encephalitis with pulmonary
edema group. There were also other such reports [10,37] which
suggested similar findings. Elevated level of blood glucose could also
forecast disease severity. When the level of blood glucose of mild
cases of HFMD increased rapidly, these mild cases would develop
into severe cases in 2–4 hours [13]. Therefore doctors would have
enough time to take measures in advance to manage the patients.
One report denoted that when the level of blood glucose was
controlled under 7.8 mmol/L the survival rate of the patients
increased 5.52 times compared to that of the patients with the level
of blood glucose .11.1 mmol/L [61]. Second, blood glucose and
WBC counts could also be used to predict the prognosis of the
illness. Elevated blood glucose and WBC counts often indicated
poor prognosis. Chang et al [19] reported that all the 11 patients
with blood glucose levels from 14.1 mmol/L to 42.2 mmol/L and
WBC counts from 11.6610
9 cells/L to 40.6610
9 cells/L died. A
patient even died 3 hours later after admission. In another report,
Lin et al [24] reported that 15 patients with an average level of
blood glucose of 7.66 mmol/L and WBC counts of 11.72610
9
cells/L all recovered after treatment while 9 patients with an
average levelofbloodglucose of13.84 mmol/Land WBC countsof
16.36610
9cells/Lallhadsequelaeordied.Thereforebloodglucose
and WBC counts were very helpful for doctors to manage HFMD
patients especially in primary care settings and resource-limited
settings such as most of the counties in China. These 2 indexes
would also help doctors to manage HFMD patients in other
countries of the world. However, they should be used combined
withclinical symptoms and other detection methods such as chest x-
ray, brain MRI, abnormal heart rate and Troponin I [62–63].
The limitations of this study should be kept in mind. First, most
of the included studies were published in Chinese, quality of the
reports may be variable. Second, in the included articles, the
detailed information of the cases of HFMD (e.g. encephalitis,
aseptic meningitis, acute flaccid paralysis, myocarditis, pulmonary
edema or hemorrhage etc.) could not be obtained; relevant
stratified analyses could not be performed to disclose more detailed
characteristics of blood glucose and WBC counts in cases of
HFMD and it was difficult to analyze the high level of
heterogeneity between studies. Third, not all necessary informa-
tion, such as age and gender of the study population, could be
obtained from all included studies.
In conclusion, our analyses suggested that blood glucose and
WBC counts increased with the severity of the illness. There was no
difference in the level of blood glucose between healthy controls and
mild cases of HFMD. WBC counts in cases infected by EV71 were
less than those in cases infected by CA16. Our results advise
monitoringof bloodglucose and WBC countsinpatients ofHFMD,
which would help doctors to manage HFMD patients greatly.
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